US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Corgi Beauty, Skincare & Aesthetics ETF

27.62

+0.09000.33%

Post-market: 27.53-0.0900-0.33%16:15 EDT

Volume:48

Turnover:1K

Market Cap:1.38M

PE:- -

High:27.62

Open:27.53

Low:27.62

Close:27.53

52wk High:29.89

52wk Low:24.32

Shares:50.00K

Float Shares:50.00K

Volume Ratio:0.17

T/O Rate:0.10%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Keurig Dr Pepper Hires Kimberly-Clark President Torres to Helm Coffee Spinoff

InflaRx Appoints Gabriela Alperovich as SVP, Global Head of Clinical Development

Coty Names Kara Langan General Manager, U.S. Consumer Beauty Division

Kimberly-Clark: Russ Torres to Depart Kimberly-Clark for External CEO Role

THOMSON REUTERS

Kimberly-Clark Announces Planned Executive Transitions and Updates to Post-Closing Leadership Team

THOMSON REUTERS

Kimberly-Clark: Leonardo Curado, Current Group President, Latin America at Kenvue, to Lead Emea Segment Effective January 1, 2027 After Deal

THOMSON REUTERS

Listerine® Launches Oral Care Counts This World Smile Day as Oral Disease Cases Rise to 3.73 Billion

THOMSON REUTERS

Hims & Hers Names Kultar Garcha UK and EMEA Chief Medical Officer

Hims & Hers Names Chief Medical Officers in the UK and Australia, Deepening Its Investment in Local Clinical Leadership

THOMSON REUTERS

Hims & Hers Health, - Appoints Kultar Garcha as Chief Medical Officer UK and Emea; Matt Vickers as Chief Medical Officer Australia

THOMSON REUTERS

Estee Lauder Cos. Cl a Stock Underperforms Wednesday When Compared to Competitors

AbbVie Wraps Key Early Trial on ABBV-722 Drug Interaction, Supporting Pipeline Confidence

AbbVie’s Bretisilocin Study Completion Signals Quiet Progress in Early-Stage Pipeline

From Walmart to Nestle, CEO Churn Sweeps Global Consumer Goods Makers

Major Drugmakers Turn to China for Licensing Deals

Kenvue Says Post-Hoc Phase III Analysis Links Earlier 5% Minoxidil Use to Higher Hair Regrowth in Men with Androgenetic Alopecia

AbbVie reports ‘positive’ results from Phase 2 APEX Part B study of zumilokibart

AbbVie Starts Phase 2 Obesity Trial of Gubra-Discovered Amylin Analog ABBV-295

Abbvie: in Phase 1 Abbv-295 Study, All Dosing Regimens Resulted in Ls Mean Weight Loss up to About 10% over 3-Month Treatment Period

THOMSON REUTERS

Abbvie: 82.2% of All Abbv-295 Treated Participants Reported Mild Adverse Events as Highest Reported Ae Severity

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigershowtime.com/stock/GLAM/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"GLAM","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GLAM\",,,,,undefined,":{"symbol":"GLAM","market":"US","secType":"STK","nameCN":"Corgi Beauty, Skincare & Aesthetics ETF","latestPrice":27.6182,"timestamp":1790971200000,"preClose":27.5282,"halted":0,"volume":48,"hourTrading":{"tag":"盘后","latestPrice":27.5282,"preClose":27.6182,"latestTime":"16:15 EDT","volume":8,"amount":220.9456,"timestamp":1790972100244,"change":-0.09,"changeRate":-0.003259,"amplitude":0},"delay":0,"changeRate":0.0032693746776034545,"floatShares":50000,"shares":50000,"eps":0,"marketStatus":"Market Closed","change":0.09,"latestTime":"10-02 16:00:00 EDT","open":27.5282,"high":27.6182,"low":27.6182,"amount":1340,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":7,"adr":0,"exchange":"CBOE","adjPreClose":27.5282,"nav":27.51,"aum":1375500,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":27.5282,"preClose":27.6182,"latestTime":"16:15 EDT","volume":8,"amount":220.9456,"timestamp":1790972100244,"change":-0.09,"changeRate":-0.003259,"amplitude":0},"volumeRatio":0.17130609980336198,"impliedVol":0.0786,"impliedVolPercentile":0.0526},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GLAM\",,,,,undefined,":{"symbol":"GLAM","floatShares":50000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.17130609980336198,"shares":50000,"dividePrice":0,"high":27.6182,"amplitude":0,"preClose":27.5282,"low":27.6182,"week52Low":24.3178,"pbRate":"--","week52High":29.89,"institutionHeld":0,"latestPrice":27.6182,"eps":0,"divideRate":0,"volume":48,"delay":0,"ttmEps":0,"open":27.5282,"prevYearClose":25.82,"prevWeekClose":28.1493,"prevMonthClose":27.766,"prevQuarterClose":27.766,"fiveDayClose":28.1493,"twentyDayClose":28.8959,"sixtyDayClose":27.8039},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GLAM\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GLAM\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GLAM\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GLAM\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2672042751","title":"Keurig Dr Pepper Hires Kimberly-Clark President Torres to Helm Coffee Spinoff","url":"https://stock-news.laohu8.com/highlight/detail?id=2672042751","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672042751?lang=en_us&edition=fundamental","pubTime":"2026-10-01 19:35","pubTimestamp":1790854500,"startTime":"0","endTime":"0","summary":"Keurig Dr Pepper has hired Russ Torres as chief executive of its coffee spinoff, plucking the executive from Kimberly Clark.Keurig Dr Pepper on Thursday said Torres, currently president and chief operating officer of Kimberly-Clark, will join the Frisco, Texas, company on Nov. 3 as CEO of its coffee operating unit prior to spinoff.Torres, who has been Kimberly-Clark's president since May 2025, is currently heading the consumer-products company's integration planning for its $40 billion acquisition of Tylenol maker Kenvue.Kimberly-Clark said Jeff Melucci, its chief strategy, business development and administrative officer, will assume oversight of the integration plans and programs, while Nelson Urdaneta, the Dallas company's chief financial officer, will oversee its synergy delivery plans.Keurig Dr Pepper, which last year unveiled plans to buy Peet's Coffee parent JDE Peet's for $18 billion and to spin off its Peet's and Keurig businesses into a pure-play coffee company, said Torres wi","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999001440.SGD","KVUE","GLAM","LU0980610538.SGD","BREW","IE00BJTD4V19.USD","RSPS","BK4177","LU1201861249.SGD","LU2463526074.USD","BK4018","LU1430594728.SGD","BK4566","LU1571399168.USD","BK4567","LU0792757196.USD","LU1989763690.USD","IE00B3T34201.USD","LU0889566641.SGD","BK4585","BK4535","LU0130102774.USD","LU1989763427.SGD","LU0708994859.HKD","JVA","LU1585245621.USD","BK4588","IE00BJTD4N35.SGD","LU1267930573.SGD","LU0029864427.USD","KDP","BK4212","BK4505","LU0130517989.USD","LU0477156953.USD","KMB","LU1267930813.SGD","LU0128525929.USD","BK4504","LU0648001328.SGD","BK4183","IE00BFXG1179.USD","LU0310800379.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672751709","title":"InflaRx Appoints Gabriela Alperovich as SVP, Global Head of Clinical Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2672751709","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672751709?lang=en_us&edition=fundamental","pubTime":"2026-10-01 19:31","pubTimestamp":1790854303,"startTime":"0","endTime":"0","summary":"InflaRx appoints Gabriela Alperovich as SVP, global head of clinical developmentInflaRx appointed Gabriela Alperovich as senior vice president and global head of clinical development, effective Oct. 1","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nNDL9m1r3P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","LU2112291526.USD","LU2596442595.SGD","LU0321505868.SGD","TRUH","LU2242652126.USD","AGNG","NDAQ","LU0198837287.USD","LU0314104364.USD","BMY","RXL","LU0823416689.USD","LU1093756168.USD","VHT","FTXH","LU2237443549.SGD","IYH","LU0795875169.SGD","LU1868837300.USD","IHE","LU2347655073.USD","IXJ","IFRX","LU0225284248.USD","IE00BQXX3F31.USD","MEDX","LU0949170772.SGD","LU0820561818.USD","PJP","BK4533","LU1061106388.HKD","LU2242646821.SGD","BK4532","PPH","CSL.AU","LU1496350171.SGD","IE000BZT7R73.USD","LU1236620834.HKD","LU2237443465.HKD","LU2125909247.SGD","IE00BSNM7G36.USD","FHLC","GLAM","LU0882574055.USD","BCDF","XLV","LU1670628061.USD","JDOC","ABBV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672751318","title":"Coty Names Kara Langan General Manager, U.S. Consumer Beauty Division","url":"https://stock-news.laohu8.com/highlight/detail?id=2672751318","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672751318?lang=en_us&edition=fundamental","pubTime":"2026-10-01 19:05","pubTimestamp":1790852708,"startTime":"0","endTime":"0","summary":"Coty names Kara Langan general manager, U.S. consumer beauty divisionCoty named Kara Langan general manager, Consumer Beauty U.S., effective Oct. 13, based in New York.Langan previously served as Ever","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nNDL3YH6rJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU1551013425.SGD","BK4532","JDOC","LU1506573853.SGD","TRUH","BK4533","LU1074936037.SGD","MEDX","RXL","LU1196500208.SGD","BMED","BK4581","GLAM","LU0345770308.USD","LU1221951046.USD","IE00B2B36J28.USD","SG9999001176.SGD","KVUE","LU0128525929.USD","PJP","LU1066053197.SGD","BK4568","IHE","LU0912757837.SGD","FTXH","XLV","GDOC","IE00BN8TJ469.HKD","IYH","IE00B19Z3B42.SGD","FHLC","LU2750360641.GBP","IE00BLSP4452.SGD","LU0345769128.USD","VHT","LU0545562505.USD","COTY","IE00B3PB1722.GBP","LU0943347566.SGD","LU1778281490.HKD","LU1228905540.USD","LU2505996681.GBP","RSPS","BK4588","JNJ","SGXZ57979304.SGD","IXJ","LU1061106388.HKD","LU2750360997.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672759766","title":"Kimberly-Clark: Russ Torres to Depart Kimberly-Clark for External CEO Role","url":"https://stock-news.laohu8.com/highlight/detail?id=2672759766","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672759766?lang=en_us&edition=fundamental","pubTime":"2026-10-01 19:00","pubTimestamp":1790852439,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nTUA2TZB06:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00BFXG1179.USD","LU0792757196.USD","LU1430594728.SGD","BK4504","LU0889566641.SGD","SG9999001440.SGD","LU0128525929.USD","LU0310800379.SGD","LU1267930573.SGD","LU1571399168.USD","RSPS","BK4567","LU1267930813.SGD","LU2463526074.USD","LU0708994859.HKD","BK4588","BK4183","GLAM","LU1585245621.USD","KMB","BK4585","IE00B3T34201.USD","KVUE","LU0029864427.USD","BK4018"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672759718","title":"Kimberly-Clark Announces Planned Executive Transitions and Updates to Post-Closing Leadership Team","url":"https://stock-news.laohu8.com/highlight/detail?id=2672759718","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672759718?lang=en_us&edition=fundamental","pubTime":"2026-10-01 19:00","pubTimestamp":1790852439,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nTUA2TZB06:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00BFXG1179.USD","RSPS","GLAM","LU0792757196.USD","LU0889566641.SGD","LU0708994859.HKD","BK4588","SG9999001440.SGD","BK4504","LU0310800379.SGD","LU1430594728.SGD","BK4567","BK4018","LU0029864427.USD","LU0128525929.USD","KVUE","LU1267930813.SGD","KMB","LU1267930573.SGD","LU1585245621.USD","LU1571399168.USD","BK4183","IE00B3T34201.USD","BK4585","LU2463526074.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672759076","title":"Kimberly-Clark: Leonardo Curado, Current Group President, Latin America at Kenvue, to Lead Emea Segment Effective January 1, 2027 After Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2672759076","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672759076?lang=en_us&edition=fundamental","pubTime":"2026-10-01 19:00","pubTimestamp":1790852439,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nTUA2TZB06:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0029864427.USD","LU1267930813.SGD","BK4585","KVUE","LU0310800379.SGD","BK4018","BK4588","KMB","LU0708994859.HKD","LU1585245621.USD","BK4567","SG9999001440.SGD","LU0792757196.USD","LU0889566641.SGD","LU1571399168.USD","IE00BFXG1179.USD","BK4504","GLAM","LU1430594728.SGD","LU1267930573.SGD","LU2463526074.USD","IE00B3T34201.USD","LU0128525929.USD","BK4183","RSPS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672596067","title":"Listerine® Launches Oral Care Counts This World Smile Day as Oral Disease Cases Rise to 3.73 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2672596067","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672596067?lang=en_us&edition=fundamental","pubTime":"2026-10-01 18:45","pubTimestamp":1790851500,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nTUA1DF8RS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0792757196.USD","KVUE","GLAM","IE00B3T34201.USD","LU0889566641.SGD","RSPS","LU1267930573.SGD","BK4585","BK4183","LU0029864427.USD","LU1267930813.SGD","LU0128525929.USD","LU0708994859.HKD","BK4588","IE00BFXG1179.USD","LU0310800379.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672756872","title":"Hims & Hers Names Kultar Garcha UK and EMEA Chief Medical Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2672756872","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672756872?lang=en_us&edition=fundamental","pubTime":"2026-10-01 18:00","pubTimestamp":1790848826,"startTime":"0","endTime":"0","summary":"Hims & Hers names Kultar Garcha UK and EMEA chief medical officerHims & Hers appointed Kultar Garcha as chief medical officer for the UK and EMEA to oversee clinical quality, safety, prescribing stand","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nNDL1qWtGf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIYY","HIMS","HMYY","HIMC","GLAM","HEAL","BK4196","THNR","HIMZ","HIMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672756816","title":"Hims & Hers Names Chief Medical Officers in the UK and Australia, Deepening Its Investment in Local Clinical Leadership","url":"https://stock-news.laohu8.com/highlight/detail?id=2672756816","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672756816?lang=en_us&edition=fundamental","pubTime":"2026-10-01 18:00","pubTimestamp":1790848800,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nTUA8M6LCZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HIMS","HEAL","HIMY","HIMZ","THNR","HIMC","BK4196","GLAM","HMYY","HIYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672568947","title":"Hims & Hers Health, - Appoints Kultar Garcha as Chief Medical Officer UK and Emea; Matt Vickers as Chief Medical Officer Australia","url":"https://stock-news.laohu8.com/highlight/detail?id=2672568947","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672568947?lang=en_us&edition=fundamental","pubTime":"2026-10-01 18:00","pubTimestamp":1790848800,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nTUA8M6LCZ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HEAL","HIMY","HIMZ","BK4196","HMYY","HIMS","GLAM","HIYY","THNR","HIMC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672178765","title":"Estee Lauder Cos. Cl a Stock Underperforms Wednesday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2672178765","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672178765?lang=en_us&edition=fundamental","pubTime":"2026-10-01 04:55","pubTimestamp":1790801700,"startTime":"0","endTime":"0","summary":"DJ Estee Lauder Cos. Cl A Stock Underperforms Wednesday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Estee Lauder Cos. Cl A  slipped 1.70% to $92.77 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index  falling 0.25% to 7,651.54 and Dow Jones Industrial Average  falling 0.86% to 50,906.05.This was the stock's second consecutive day of losses.Estee Lauder Cos. Cl A closed 23.73% short of its 52-week high of $121.64, which the company reached on February 3rd.The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Johnson & Johnson  fell 1.06% to $264.74, Procter & Gamble Co.  fell 2.05% to $145.28, and Coty Inc. Cl A  fell 2.97% to $2.61.Trading volume  eclipsed its 50-day average volume of 3.1 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 30, 2026.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDX","LU0661504455.SGD","EL","BK4183","LU0787776722.HKD","UGE","FHLC","FTXH","JNJ","LU1066051811.HKD","LU2505996509.AUD","BMED","LU0124676726.USD","IXJ","XLV","IYH","LU1003077747.HKD","LU1196500208.SGD","IE00B1BXHZ80.USD","LU1585245621.USD","XLP","LU1496350502.SGD","BK4588","RXL","BK4533","PG","LU1267930813.SGD","LU2592432038.USD","VHT","GLAM","BK4558","LU2505996681.GBP","LU1868837136.USD","PJP","SG9999015341.SGD","TRUO","GDOC","COTY","LU0690374961.EUR","LU1059921491.USD","LU2347655156.SGD","IHE","LU2552382132.HKD","JDOC","LU1023059063.AUD","TRUH","LU0882574055.USD","LU0057025933.USD","FSTA","IE000M9KFDE8.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672014786","title":"AbbVie Wraps Key Early Trial on ABBV-722 Drug Interaction, Supporting Pipeline Confidence","url":"https://stock-news.laohu8.com/highlight/detail?id=2672014786","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672014786?lang=en_us&edition=fundamental","pubTime":"2026-10-01 00:30","pubTimestamp":1790785840,"startTime":"0","endTime":"0","summary":"Abbvie ($ABBV) announced an update on their ongoing clinical study. AbbVie has completed a Phase 1 study called “A Phase 1 Study to Evaluate the Ef...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/abbvie-wraps-key-early-trial-on-abbv-722-drug-interaction-supporting-pipeline-confidence?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/abbvie-wraps-key-early-trial-on-abbv-722-drug-interaction-supporting-pipeline-confidence?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0689472784.USD","IE0002270589.USD","LU1093756168.USD","LU1430594728.SGD","LU1934455194.USD","LU1929549753.HKD","LU1093756325.SGD","ABBV","PPH","LU0861579265.USD","RXL","BK4139","LU0795875169.SGD","SG9999001440.SGD","LU0128525929.USD","LU0310800379.SGD","LU2468319806.SGD","BK4533","JDOC","LU0738911758.USD","LU1934455863.HKD","LU0122379950.USD","LU0417517546.SGD","XLV","FTXH","IE00BSNM7G36.USD","LU1720051108.HKD","BK4534","LU0289739699.SGD","LU0256863902.USD","LU0820561818.USD","PJP","GLAM","LU0965509010.AUD","VHT","LU1061106388.HKD","AGNG","TRUH","IYH","LU1839511570.USD","LU1496350171.SGD","BK4585","MEDX","FHLC","IE00B19Z3B42.SGD","LU0029864427.USD","LU2089284900.SGD","IXJ","SG9999015978.USD","IE000MB6IJN5.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672860737","title":"AbbVie’s Bretisilocin Study Completion Signals Quiet Progress in Early-Stage Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2672860737","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672860737?lang=en_us&edition=fundamental","pubTime":"2026-10-01 00:30","pubTimestamp":1790785833,"startTime":"0","endTime":"0","summary":"Abbvie ($ABBV) announced an update on their ongoing clinical study. AbbVie has completed a Phase 1 study called “An Open-Label Study to Evaluate th...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/abbvies-bretisilocin-study-completion-signals-quiet-progress-in-early-stage-pipeline?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/abbvies-bretisilocin-study-completion-signals-quiet-progress-in-early-stage-pipeline?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0545039389.USD","BK4534","LU1057294990.SGD","LU0289739699.SGD","LU2129689431.USD","LU2129689605.HKD","LU1061106388.HKD","LU1244550221.USD","BK4097","JDOC","PRGS","LU1244550494.USD","LU1718418525.SGD","IXJ","LU0708994859.HKD","MEDX","LU1934455863.HKD","RXL","LU2347655073.USD","ABBV","LU0511384066.AUD","LU0114720955.EUR","LU0170899867.USD","IE00BJT1NW94.SGD","LU1162221912.USD","TRUH","IYH","IE00BSNM7G36.USD","LU2237443895.HKD","AGNG","LU1989772840.SGD","XLV","LU2237443382.USD","PPH","LU2089283258.USD","IE00B42XCP33.USD","PJP","LU0256863902.USD","IE00BGHQF631.EUR","FTXH","FHLC","LU2089284900.SGD","LU0553294199.USD","IE0009355771.USD","VHT","LU2237443465.HKD","LU0943347566.SGD","SG9999003800.SGD","GLAM","LU0823416689.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671075912","title":"From Walmart to Nestle, CEO Churn Sweeps Global Consumer Goods Makers","url":"https://stock-news.laohu8.com/highlight/detail?id=2671075912","media":"Reuters","labels":["executive","event","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671075912?lang=en_us&edition=fundamental","pubTime":"2026-09-30 21:18","pubTimestamp":1790774302,"startTime":"0","endTime":"0","summary":"FACTBOX-From Walmart to Nestle, CEO churn sweeps global consumer goods makersSept 30 (Reuters)-Toymaker MattelMAT.Oand Cheerios maker General MillsGIS.Non Wednesday named new chief executive officers,","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nL6N45M0TB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,event,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPFE0main","SJM","ULVR.UK","LU0550127509.SGD","BK4146","WMTI","FSTA","BBY","DG","HSY","TGT","GIS","STYL","LULU","03165","FBIN","RSPS","PG","KR","TRUO","WEN","COTY","SKO00main","BK4567","DPZ","LU1046421449.USD","WMT","MAT","KO","NICO","HRL","UGE","BREW","MO","LULG","NKE","LU2471134523.USD","GLAM","DGE.UK","RTH","KHC","KSS","TSN","SG9999014559.SGD","KVUE","PBJ","XLP","CAG","SWK","FTXG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671051201","title":"Major Drugmakers Turn to China for Licensing Deals","url":"https://stock-news.laohu8.com/highlight/detail?id=2671051201","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671051201?lang=en_us&edition=fundamental","pubTime":"2026-09-30 20:17","pubTimestamp":1790770671,"startTime":"0","endTime":"0","summary":"FACTBOX-Major drugmakers turn to China for licensing dealsSept 30 (Reuters)-Novo NordiskNOVOb.COsaid on Tuesday it will pay up to$2.6 billionto Jiangsu Hengrui Pharmaceuticals600276.SSfor the rights t","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nL4N45M0T3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LLY","01530","ABBV","JDOC","IXJ","LLYZ","LLYX","ILDR","PJP","GDOC","PAWZ","01801","THNR","IHE","VHT","KURE","MEDI","XLV","CURE","GSK.UK","FTXH","GLAM","MEDX","TMED","AGNG","CANC","FHLC","TRUH","LLII","BMED","RSHO","WDNA","ELIL","BNTX","ELIS","HRTS","MRK","MHIP","OZEM","09926","IYH","688331","CGNX","03692","00013","PPH","PFE","SMMT","RXL","600276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671205985","title":"Kenvue Says Post-Hoc Phase III Analysis Links Earlier 5% Minoxidil Use to Higher Hair Regrowth in Men with Androgenetic Alopecia","url":"https://stock-news.laohu8.com/highlight/detail?id=2671205985","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671205985?lang=en_us&edition=fundamental","pubTime":"2026-09-30 18:45","pubTimestamp":1790765154,"startTime":"0","endTime":"0","summary":"Kenvue says post-hoc Phase III analysis links earlier 5% minoxidil use to higher hair regrowth in men with androgenetic alopeciaKenvue outlined new clinical and preclinical findings slated for present","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nNDL8jHf4f:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0128525929.USD","LU0345770308.USD","FHLC","BMED","LU0787776722.HKD","KVUE","LU0289739699.SGD","XLV","IE00BVYPNV92.GBP","MEDX","LU1267930573.SGD","LU2089984988.USD","BK4592","IYH","VHT","JDOC","RXL","LU1778281490.HKD","IE00B2B36J28.USD","LU0738911758.USD","TRUH","LU2236285917.USD","SG9999001440.SGD","IE0002141913.USD","LU2471134952.CNY","LU1145028129.USD","GLAM","IE00B4R5TH58.HKD","JNJ","IXJ","LU0792757196.USD","LU1244550221.USD","LU2487616109.SGD","LU2471134796.USD","SG9999001176.USD","IHE","RSPS","PJP","GDOC","SG9999001176.SGD","BK4581","LU0689626769.HKD","LU1196500208.SGD","FTXH","LU1032955483.USD","IE000WAW04H5.SGD","LU0912757837.SGD","LU0661504455.SGD","LU1003077747.HKD","LU1894683348.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671089252","title":"AbbVie reports ‘positive’ results from Phase 2 APEX Part B study of zumilokibart","url":"https://stock-news.laohu8.com/highlight/detail?id=2671089252","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671089252?lang=en_us&edition=fundamental","pubTime":"2026-09-30 17:55","pubTimestamp":1790762110,"startTime":"0","endTime":"0","summary":"AbbVie (ABBV) announced that the primary results from the ongoing Phase 2 APEX Part B Dose-Regimen-Finding Study, evaluating zumilokibart, in adult...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/abbvie-reports-positive-results-from-phase-2-apex-part-b-study-of-zumilokibart-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/abbvie-reports-positive-results-from-phase-2-apex-part-b-study-of-zumilokibart-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4566","IE000F7OJYX1.SGD","LU0234572021.USD","VHT","IE00BLSP4452.SGD","BK4550","LU0029864427.USD","LU0395794307.EUR","LU0553294199.USD","LU0256863811.USD","FTXH","AGNG","PJP","LU1732800096.USD","LU2023251221.USD","LU2347655073.USD","RXL","IXJ","LU1430594728.SGD","LU2089284900.SGD","LU1057294990.SGD","LU1720051108.HKD","PPH","LU1989772923.USD","IE00B2B36J28.USD","IE0002141913.USD","LU1037948541.HKD","IE00B19Z3581.USD","ABBV","IYH","LU0114720955.EUR","LU0203345920.USD","LU0472753341.HKD","LU2347655156.SGD","MEDX","LU0820561909.HKD","LU0057025933.USD","LU1670628061.USD","BK4533","IE000SO60NU8.SGD","LU1934455277.USD","IE00B3PB1722.GBP","IE0000B7K699.USD","GLAM","JDOC","IE00BJJMRZ35.SGD","XLV","TRUH","LU0058720904.USD","FHLC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671208859","title":"AbbVie Starts Phase 2 Obesity Trial of Gubra-Discovered Amylin Analog ABBV-295","url":"https://stock-news.laohu8.com/highlight/detail?id=2671208859","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671208859?lang=en_us&edition=fundamental","pubTime":"2026-09-30 17:51","pubTimestamp":1790761876,"startTime":"0","endTime":"0","summary":"AbbVie starts Phase 2 obesity trial of Gubra-discovered amylin analog ABBV-295Gubra flagged AbbVie’s detailed Phase 1 results for obesity candidate ABBV-295, presented at EASD 2026 in Milan.Data showe","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nNDL9BGxfn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1934455863.HKD","SG9999015952.SGD","VHT","LU2112291526.USD","LU0738911758.USD","FTXH","LU0170899867.USD","AGNG","LU0310800379.SGD","LU1983299246.USD","PJP","LU2237443622.USD","LU0985320562.USD","RXL","LU0912757837.SGD","LU1923622614.USD","LU0708994859.HKD","IXJ","LU0661504455.SGD","LU1430594728.SGD","IE00BJT1NW94.SGD","LU0289961442.SGD","LU0289739343.SGD","PPH","LU1989772923.USD","LU1093756168.USD","IE00B4R5TH58.HKD","LU1037948541.HKD","ABBV","IYH","LU2237443978.SGD","LU1718418525.SGD","MEDX","IE00BVYPNV92.GBP","LU0456855351.SGD","LU0820561909.HKD","LU1037948897.HKD","LU0417517546.SGD","LU1267930490.SGD","LU2357305700.SGD","GLAM","LU0859254822.USD","JDOC","LU2125909247.SGD","LU0069063385.USD","LU0310799852.SGD","XLV","TRUH","LU0058720904.USD","FHLC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671270785","title":"Abbvie: in Phase 1 Abbv-295 Study, All Dosing Regimens Resulted in Ls Mean Weight Loss up to About 10% over 3-Month Treatment Period","url":"https://stock-news.laohu8.com/highlight/detail?id=2671270785","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671270785?lang=en_us&edition=fundamental","pubTime":"2026-09-30 17:45","pubTimestamp":1790761500,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nP8N3WW07N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0234570918.USD","LU0395794307.EUR","BK4559","VHT","XLV","LU1093756168.USD","PPH","BK4534","IE00BJT1NW94.SGD","LU0868494617.USD","AGNG","LU1934455194.USD","LU2129689431.USD","IE0004445239.USD","FHLC","TRUH","LU0320765646.SGD","MEDX","LU1839511570.USD","GLAM","LU1244550494.USD","SG9999015952.SGD","IE00BJJMRZ35.SGD","IE000BZT7R73.USD","IYH","LU0124676726.USD","JDOC","LU0058720904.USD","LU0198837287.USD","LU0289739343.SGD","RXL","LU0203345920.USD","IE00BBT3K403.USD","IE0002141913.USD","PJP","LU0057025933.USD","LU1236620750.USD","ABBV","LU0203347892.USD","LU0949170772.SGD","LU1934455863.HKD","IE00BGHQF631.EUR","LU1267930490.SGD","IXJ","FTXH","LU0820561909.HKD","LU1037948897.HKD","LU2087621335.USD","LU0417517546.SGD","LU1983299246.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671270207","title":"Abbvie: 82.2% of All Abbv-295 Treated Participants Reported Mild Adverse Events as Highest Reported Ae Severity","url":"https://stock-news.laohu8.com/highlight/detail?id=2671270207","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671270207?lang=en_us&edition=fundamental","pubTime":"2026-09-30 17:45","pubTimestamp":1790761500,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nP8N3WW07N:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1720051017.SGD","BK4139","JDOC","LU0289739699.SGD","PPH","LU1989771016.USD","IXJ","LU2357627491.SGD","LU2237443549.SGD","LU0689626769.HKD","LU0128525929.USD","LU2087621335.USD","LU0057025933.USD","AGNG","IE000BZT7R73.USD","XLV","MEDX","LU1267930573.SGD","LU0310800379.SGD","PJP","GLAM","LU0795875169.SGD","IYH","BK4533","TRUH","FHLC","LU0395794307.EUR","LU1989772840.SGD","IE00BLSP4239.USD","LU2347655156.SGD","LU0985320562.USD","IE0009355771.USD","IE0002141913.USD","IE00BSNM7G36.USD","FTXH","SG9999011175.SGD","LU0158827948.USD","LU0545039389.USD","LU0943347566.SGD","BK4534","LU2089283258.USD","LU1244550577.SGD","LU1430594728.SGD","RXL","VHT","SG9999015978.USD","LU1037948897.HKD","LU1732800096.USD","ABBV","IE000SO60NU8.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":200,"code":"91000000","status":"200"}]}}